Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,972,812 papers from all fields of science
Search
Sign In
Create Free Account
denileukin diftitox/dexamethasone
Known as:
DAB389-IL2/DM
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Dexamethasone
denileukin diftitox
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
A Phase II Trial of Denileukin Diftitox in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer
M. Gerena-Lewis
,
J. Crawford
,
+11 authors
A. Jazieh
American Journal of Clinical Oncology
2009
Corpus ID: 9473507
Introduction:Denileukin diftitox, a chimeric protein, uses the cytocidal properties of diphtheria toxin to cells expressing…
Expand
2008
2008
Durable complete remission of mycosis fungoides following erythroderma induced by denileukin diftitox.
Rebecca A. Kazin
,
Paul Bujanauskas
,
E. Vonderheid
Journal of American Academy of Dermatology
2008
Corpus ID: 205500538
Highly Cited
2007
Highly Cited
2007
IL-2 immunotoxin denileukin diftitox reduces regulatory T cells and enhances vaccine-mediated T-cell immunity.
M. Litzinger
,
R. Fernando
,
T. Curiel
,
D. Grosenbach
,
J. Schlom
,
C. Palena
Blood
2007
Corpus ID: 9428084
CD4+CD25+Foxp3+ regulatory T (Treg) cells have been implicated in the lack of effective antitumor immunity. Denileukin diftitox…
Expand
2007
2007
Vision loss following denileukin diftitox treatment: A case report of possible posterior ischemic optic neuropathy
Meyeon Park
,
Grant T. Liu
,
+5 authors
Ellen J. Kim
Leukemia and Lymphoma
2007
Corpus ID: 34764596
Denileukin diftitox (DD; Ontak, Eisai, Woodcliff Lake, NJ) is an FDA-approved targeted therapy for cutaneous T-cell lymphoma…
Expand
2006
2006
Biologic correlates of response and survival in patients with cutaneous T-cell lymphoma treated with denileukin diftitox.
K. Chin
,
F. Foss
Clinical Lymphoma & Myeloma
2006
Corpus ID: 10180499
BACKGROUND Denileukin diftitox, a fusion protein consisting of peptide sequences for the enzymatically active and membrane…
Expand
Highly Cited
2005
Highly Cited
2005
Inability of a Fusion Protein of IL-2 and Diphtheria Toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to Eliminate Regulatory T Lymphocytes in Patients With Melanoma
P. Attia
,
A. Maker
,
Leah R. Haworth
,
L. Rogers-Freezer
,
S. Rosenberg
Journal of immunotherapy
2005
Corpus ID: 10447474
Elimination of regulatory T lymphocytes may provide a way to break self-tolerance and unleash the anti-tumor properties of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE